Economic Evaluation of Robotic Radiosurgery System for Prostate Cancer Treatments in the Czech Republic

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68407700%3A21460%2F19%3A00321389" target="_blank" >RIV/68407700:21460/19:00321389 - isvavai.cz</a>

Výsledek na webu

<a href="http://dx.doi.org/10.1007/978-981-10-9038-7_20" target="_blank" >http://dx.doi.org/10.1007/978-981-10-9038-7_20</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/978-981-10-9038-7_20" target="_blank" >10.1007/978-981-10-9038-7_20</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Economic Evaluation of Robotic Radiosurgery System for Prostate Cancer Treatments in the Czech Republic

Popis výsledku v původním jazyce

The purpose of this study was to carry out the economic evaluation of robotic stereotactic body radiation therapy (rSBRT) in comparison with conventional intensity-modulated radiation therapy (IMRT) for the treatment of localized prostate cancer in the Czech Republic. Cost-utility analysis was used for the economic evaluation of both technologies based on their costs and the number of quality-adjusted life years gained (QALYs). Utilities of both technologies were identified in literature. An estimation of treatment costs was obtained from publicly available secondary sources for the Czech Republic. The cost-utility analysis was conducted from provider’s perspective for three scenarios (optimistic, realistic, and pessimistic). According to the results of cost-utility analysis, in every scenario concerned IMRT was both more effective and less costly than rSBRT. Namely, in realistic scenario, IMRT and rSBRT accrued 9.96 QALY/53,198 CZK and 9.93 QALY/79,956 CZK, respectively. rSBRT reached the same or lower values of the cost-utility ratio than IMRT in situation, when the acquisition price of rSBRT equipment was lower than CZK 58 million in the realistic scenario. Under the conditions of the Czech healthcare system, IMRT was more cost-effective than rSBRT for localized prostate cancer treatment in all the analyzed scenarios.

Název v anglickém jazyce

Economic Evaluation of Robotic Radiosurgery System for Prostate Cancer Treatments in the Czech Republic

Popis výsledku anglicky

The purpose of this study was to carry out the economic evaluation of robotic stereotactic body radiation therapy (rSBRT) in comparison with conventional intensity-modulated radiation therapy (IMRT) for the treatment of localized prostate cancer in the Czech Republic. Cost-utility analysis was used for the economic evaluation of both technologies based on their costs and the number of quality-adjusted life years gained (QALYs). Utilities of both technologies were identified in literature. An estimation of treatment costs was obtained from publicly available secondary sources for the Czech Republic. The cost-utility analysis was conducted from provider’s perspective for three scenarios (optimistic, realistic, and pessimistic). According to the results of cost-utility analysis, in every scenario concerned IMRT was both more effective and less costly than rSBRT. Namely, in realistic scenario, IMRT and rSBRT accrued 9.96 QALY/53,198 CZK and 9.93 QALY/79,956 CZK, respectively. rSBRT reached the same or lower values of the cost-utility ratio than IMRT in situation, when the acquisition price of rSBRT equipment was lower than CZK 58 million in the realistic scenario. Under the conditions of the Czech healthcare system, IMRT was more cost-effective than rSBRT for localized prostate cancer treatment in all the analyzed scenarios.

Druh

D - Stať ve sborníku

CEP obor

—

OECD FORD obor

20601 - Medical engineering

Projekt

—

Návaznosti

S - Specificky vyzkum na vysokych skolach<br>I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2019

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název statě ve sborníku

World Congress on Medical Physics and Biomedical Engineering 2018 (Vol. 2)

ISBN

978-981-10-9037-0

ISSN

1680-0737

e-ISSN

—

Počet stran výsledku

6

Strana od-do

113-118

Název nakladatele

Springer Nature Singapore Pte Ltd.

Místo vydání

—

Místo konání akce

Prague

Datum konání akce

3. 6. 2018

Typ akce podle státní příslušnosti

WRD - Celosvětová akce

Kód UT WoS článku

000449742700020